Allstate Corporation’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $473K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $545K | Buy |
|
|||||
|
2024
Q4 | $397K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $503K | Buy |
|
|||||
|
2022
Q3 | $448K | Buy |
|
|||||
|
2022
Q2 | $350K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $338K | Sell |
|
|||||
|
2021
Q2 | $369K | Buy |
|
|||||
|
2021
Q1 | $345K | Sell |
|
|||||
|
2020
Q4 | $455K | Buy |
|
|||||
|
2020
Q3 | $329K | Sell |
|
|||||
|
2020
Q2 | $490K | Sell |
|
|||||
|
2020
Q1 | $362K | Sell |
|
|||||
|
2019
Q4 | $1.4M | Hold |
|
|||||
|
2019
Q3 | $1.17M | Buy |
|
|||||
|
2019
Q2 | $1.08M | Buy |
|